Bull Harbor Capital’s Pfizer PFE Stock Holding History

Bull Harbor Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$693K	Buy	28,765 +12,235	+74%	+$320K	0.14%	226
2026 Q1	$464K	Buy	+16,530	New	+$440K	0.12%	250

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bull Harbor Capital's PFE Position: Q2 2026 in Review

Bull Harbor Capital increased its Pfizer (PFE) stake by 74% in Q2 2026, buying an estimated $320K and bringing the position to 28,765 shares worth $693K. The position accounts for 0.14% of the portfolio, ranked #226.

Bull Harbor Capital first reported a position in PFE in Q1 2026 and has held it in 2 quarters since. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Bull Harbor Capital held 28,765 shares of Pfizer worth $693K as of Q2 2026.
Bull Harbor Capital bought 12,235 Pfizer shares in Q2 2026, an estimated $320K.
Pfizer made up 0.14% of Bull Harbor Capital's portfolio in Q2 2026, its #226 holding.
Bull Harbor Capital first reported a position in Pfizer in Q1 2026 and has held it in 2 quarters since.
2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bull Harbor Capital's 13F filing for Q2 2026, filed 10 Aug 2026.